XML 60 R41.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended
Nov. 27, 2023
Sep. 26, 2023
Jun. 30, 2023
Nov. 06, 2022
Oct. 07, 2022
Jun. 30, 2022
Jun. 17, 2022
Jun. 30, 2021
May 11, 2021
Apr. 09, 2021
Aug. 12, 2020
Aug. 07, 2020
Aug. 01, 2020
Jul. 15, 2020
Jul. 14, 2020
Jun. 30, 2022
Jun. 30, 2021
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Jun. 26, 2023
Jun. 06, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Shares outstanding                                   674,896     674,896       389,479
Stock option vested exercisable term                                         28 months        
Stock based compensation                                   $ 112,106 $ 396,883   $ 669,146 $ 1,160,649      
Number of fully vested option exercisable                                   313,959     313,959       281,979
Share based compensation vesting rights, percentage                                         12.50%        
Total deferred compensation expense for outstanding value of unvested stock options                                         $ 808,000        
Fair market value, per share                                         $ 2.45        
Intrinsic value                                   $ 0     $ 0        
Outstanding stock options to acquire shares of common stock not vested                                   360,938     360,938        
Common Stock [Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Stock price per share                                   $ 57.00     $ 57.00        
Director [Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Stock options description                                       the Board of Directors, in accordance with the Company’s cash and equity compensation package for members of the Board of Directors, granted to each of the five non-officer directors of the Company stock options to purchase 10,000 shares (a total of 50,000 shares) of the Company’s common stock, exercisable for a period of five years at an exercise price of $7.40 per share (the closing market price on the grant date), vesting 12.5% on the last day of each subsequent calendar quarter-end until fully vested, subject to continued service. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $316,700 ($6.334 per share), which is being charged to operations ratably from July 1, 2022 through June 30, 2024. The Company recorded charges to general and administrative costs in the consolidated statement of operations of $23,916 and $39,860 for the three months ended September 30, 2023 and 2022, respectively, and $70,965 and $39,860 for the nine months ended September 30, 2023 and 2022, respectively, with respect to these stock options.          
Stock option vested exercisable term           5 years 5 years                                    
Fair value of stock options                                 $ 10,000                
Stock price per share     $ 5.88 $ 20.00   $ 50,000   $ 6.334               $ 50,000 $ 6.334     $ 50,000          
Stock based compensation                                   $ 23,916 39,860   $ 70,965 39,860      
Stock options are exercisable price per share       $ 5.025   $ 7.40                   $ 7.40       $ 7.40          
Number of fully vested option exercisable     10,000 10,000                                          
Director [Member] | Common Stock [Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Number of fully vested option exercisable       20,000                                          
Five Non Officer Directors [Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Stock options description               the Board of Directors, in accordance with the Company’s cash and equity compensation package for members of the Board of Directors, granted to each of the five non-officer directors of the Company stock options to purchase 10,000 shares (a total of 50,000 shares) of the Company’s common stock, exercisable for a period of five years at an exercise price of $30.30 per share (the closing market price on the grant date), vesting 12.5% on the last day of each subsequent calendar quarter-end until fully vested, subject to continued service. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $1,421,095 ($28.423 per share), which was charged to operations ratably from July 1, 2021 through June 30, 2023. The Company recorded charges to general and administrative costs in the consolidated statement of operations of $0 and $179,100 for the three months ended September 30, 2023 and 2022, respectively, and $211,412 and $531,455 for the nine months ended September 30, 2023 and 2022, respectively, with respect to these stock options.                                  
Stock option vested exercisable term               5 years                                  
Fair value of stock options       $ 43,264                       $ 316,700 $ 1,421,095                
Stock price per share       $ 4.326       $ 28.423                 $ 28.423                
Stock based compensation                                   0 179,100   211,412 531,455      
Number of fully vested option exercisable               10,000                 10,000                
Non Officer Directors [Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Stock options are exercisable price per share               $ 30.30                 $ 30.30                
Number of fully vested option exercisable               50,000                 50,000                
BasvanderBaan [Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Stock options description             the Board of Directors appointed Bas van der Baan to the Board of Directors. In connection with his appointment to the Board of Directors, and in accordance with the Company’s cash and equity compensation package for members of the Board of Directors, Mr. Baan was granted stock options to purchase 25,000 shares of the Company’s common stock, exercisable for a period of five years at an exercise price of $7.40 per share (the closing market price on the grant date), vesting 50% on the grant date and the remainder vesting 12.5% on the last day of each subsequent calendar quarter-end until fully vested, subject to continued service. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $158,525 ($6.341 per share), of which $79,263 was attributable to the portion of the stock options fully vested on June 17, 2022 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options is being charged to operations ratably from June 17, 2022 through June 30, 2024. The Company recorded charges to general and administrative costs in the consolidated statement of operations of $9,801 and $9,801 for the three months ended September 30, 2023 and 2022, respectively, and $29,084 and $90,449 for the nine months ended September 30, 2023 and 2022, respectively, with respect to these stock options.                                    
Fair value of stock options             $ 158,525                                    
Stock price per share             $ 6.341                                    
Stock based compensation                                   9,801 9,801   29,084 90,449      
Stock options are exercisable price per share             $ 7.40                                    
Number of fully vested option exercisable             25,000                                    
Stock options granted to purchase common stock, issued             $ 79,263                                    
Four Officers [Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Fair value of stock options       $ 262,560                                          
Stock price per share       $ 3.282                                          
Stock based compensation                                   16,528     49,053        
Number of fully vested option exercisable       80,000                                       40,000  
Share based compensation vesting rights, percentage       25.00%                                          
Share based compensation issuance, percentage       25.00%                                          
Stock options granted to purchase common stock, issued       80,000                                          
Four Non Officers[Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Fair value of stock options     $ 192,593                                            
Stock price per share     $ 4.8131                                            
Stock based compensation                                   24,232     24,232        
Share based compensation vesting rights, percentage     12.50%                                            
Eric J. Forman [Member] | Employment Agreement [Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Options, grants in period, gross                           5,833                      
Stock options description                           On July 15, 2020, as amended on August 12, 2020, in connection with the employment agreement entered into with Eric J. Forman, Mr. Forman was granted stock options to purchase 5,833 shares of the Company’s common stock. The options can be exercised on a cashless basis. The options are exercisable for a period of five years at an exercise price of $71.40 per share, which was equal to the closing market price of the Company’s common stock on the grant date. The options vested 25% on August 12, 2020, 2021 and 2022, respectively, with the final 25% vesting on August 12, 2023, subject to continued service. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $400,855 ($68.718 per share), of which $100,214 was attributable to the portion of the stock options fully vested on August 12, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options was charged to operations ratably from August 12, 2020 through August 12, 2023. The Company recorded charges to general and administrative costs in the consolidated statement of operations of $11,806 and $25,259 for the three months ended September 30, 2023 and 2022, respectively, and $61,501 and $74,954 for the nine months ended September 30, 2023 and 2022, respectively, with respect to these stock options.                      
Stock option vested exercisable term                           5 years                      
Fair value of stock options                           $ 400,855                      
Stock price per share                           $ 68.718                      
Stock options fully vested amount, fair value                     $ 100,214                            
Stock based compensation                                   11,806 25,259   61,501 74,954      
Dr. James Miser [Member] | Employment Agreement [Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Options, grants in period, gross                         8,333                        
Stock options description                         Dr. James S. Miser, M.D., Dr. Miser was granted stock options to purchase 8,333 shares of the Company’s common stock. The options can be exercised on a cashless basis. The options are exercisable for a period of five years at an exercise price of $71.40 per share, which was equal to the closing market price of the Company’s common stock on the effective date of the employment agreement. The options vested 25% on August 1, 2020, 2021 and 2022, respectively, with the final 25% vesting on August 1, 2023, subject to continued service. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $572,650 ($68.718 per share), of which $143,163 was attributable to the portion of the stock options fully vested on August 1, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options was charged to operations ratably from August 1, 2020 through August 1, 2023. The Company recorded charges to general and administrative costs in the consolidated statement of operations of $12,551 and $36,085 for the three months ended September 30, 2023 and 2022, respectively, and $83,544 and $107,078 for the nine months ended September 30, 2023 and 2022, respectively, with respect to these stock options.                        
Stock option vested exercisable term                       5 years                          
Fair value of stock options                         $ 572,650                        
Stock price per share                         $ 68.718                        
Stock options fully vested amount, fair value                         $ 143,163                        
Stock based compensation                                   12,551 36,085   83,544 107,078      
Stock options are exercisable price per share                         $ 71.40                        
Robert N. Weingarten [Member] | Director [Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Number of fully vested option exercisable                     5,833                            
Robert N. Weingarten [Member] | Employment Agreement [Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Stock options description                     On August 12, 2020, in connection with the employment agreement entered into with Robert N. Weingarten, Mr. Weingarten was granted stock options to purchase 5,833 shares of the Company’s common stock. The options can be exercised on a cashless basis. The options are exercisable for a period of five years at an exercise price of $71.40 per share, which was equal to the closing market price of the Company’s common stock on the grant date. The options vested 25% on August 12, 2020, 2021 and 2022, respectively, with the final 25% vesting on August 12, 2023, subject to continued service. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $400,855 ($68.718 per share), of which $100,214 was attributable to the portion of the stock options fully vested on August 12, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options was charged to operations ratably from August 12, 2020 through August 12, 2023. The Company recorded charges to general and administrative costs in the consolidated statement of operations of $11,806 and $25,259 for the three months ended September 30, 2023 and 2022, respectively, and $61,501 and $74,954 for the nine months ended September 30, 2023 and 2022, respectively, with respect to these stock options.                            
Stock option vested exercisable term                     5 years                            
Fair value of stock options                     $ 400,855                            
Stock price per share                     $ 68.718                            
Stock options fully vested amount, fair value                     $ 100,214                            
Stock based compensation                                   11,806 25,259   61,501 74,954      
Stock options are exercisable price per share                     $ 71.40                            
Mr Schwartberg [Member] | Director [Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Stock options description                   On April 9, 2021, the Board of Directors appointed Gil Schwartzberg to fill the vacancy created by a former director’s resignation. In connection with his appointment to the Board of Directors, and in accordance with the Company’s cash and equity compensation package for members of the Board of Directors, Mr. Schwartzberg was granted stock options to purchase 25,000 shares of the Company’s common stock, exercisable for a period of five years at an exercise price of $32.00 per share (the closing market price on the grant date), vesting 50% on the grant date and the remainder vesting 12.5% on the last day of each subsequent calendar quarter-end until fully vested, subject to continued service. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $753,611 ($30.144 per share), of which $376,800 was attributable to the portion of the stock options fully vested on April 9, 2021 and was therefore charged to operations on that date. Although the remaining unvested portion of the fair value of the stock options was being charged to operations ratably from April 9, 2021 through June 30, 2023, the vesting of these stock options terminated on October 30, 2022 as a result of the death of Mr. Schwartzberg on that date. The Company recorded charges to general and administrative costs in the consolidated statement of operations of $42,692 and $126,684 for the three months and nine months ended September 30, 2022, respectively, with respect to these stock options.                              
Stock option vested exercisable term                   5 years                              
Fair value of stock options                   $ 753,611                              
Stock price per share                   $ 30.144                              
Stock options fully vested amount, fair value                   $ 376,800                              
Stock based compensation                                     42,692     126,684      
Stock options are exercisable price per share                   $ 32.00                              
Number of fully vested option exercisable                   25,000                              
Ms.Regina Brown [Member] | Director [Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Stock options description                 the Board of Directors appointed Regina Brown to the Board of Directors. In connection with her appointment to the Board of Directors, and in accordance with the Company’s cash and equity compensation package for members of the Board of Directors, Ms. Brown was granted stock options to purchase 25,000 shares of the Company’s common stock, exercisable for a period of five years at an exercise price of $28.00 per share (the closing market price on the grant date), vesting 50% on the grant date and the remainder vesting 12.5% on the last day of each subsequent calendar quarter-end until fully vested, subject to continued service. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $658,363 ($26.335 per share), of which $329,188 was attributable to the portion of the stock options fully vested on May 11, 2021 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options was charged to operations ratably from May 11, 2021 through June 30, 2023. The Company recorded charges to general and administrative costs in the consolidated statement of operations of $0 and $38,827 for the three months ended September 30, 2023 and 2022, respectively, and $76,388 and $115,215 for the nine months ended September 30, 2023 and 2022, respectively, with respect to these stock options.                                
Stock option vested exercisable term                 5 years                                
Fair value of stock options                 $ 658,363                                
Stock price per share                 $ 26.335                                
Stock options fully vested amount, fair value                 $ 329,188                                
Stock based compensation                                   0 $ 38,827   76,388 $ 115,215      
Stock options are exercisable price per share                 $ 28.00                                
Number of fully vested option exercisable                 25,000                                
Mr Vander Baan [Member] | Employment Agreement [Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Options, grants in period, gross   250,000                                              
Fair value of stock options   $ 403,066                                              
Stock price per share   $ 1.95                                         $ 1.612    
Stock based compensation                                   $ 1,466     $ 1,466        
2020 Stock Incentive Plan [Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Common shares avaliable for issuable         180,000                                        
Options, grants in period, gross         413,333                                        
Shares outstanding                                   136,980     136,980        
2020 Stock Incentive Plan [Member] | Subsequent Event [Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Common shares avaliable for issuable 336,667                                                
Options, grants in period, gross 750,000                                                
Shares outstanding 550,313                                                
Shares were available for issuance 199,687                                                
2020 Stock Incentive Plan [Member] | Maximum [Member]                                                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                                                  
Number of restricted stock issued                             233,333